UnitedHealth Group Incorporated $UNH Shares Bought by GDS Wealth Management

Key Points

• GDS Wealth Management increased its holdings in UnitedHealth Group by 9.4%, owning a total of 25,325 shares valued at approximately $13.26 million at the end of the first quarter.
• Several hedge funds, including Banco Bilbao Vizcaya Argentaria and Van Lanschot Kempen Investment Management, also significantly increased their stakes in UnitedHealth Group during the same period.
• UnitedHealth Group recently reported earnings of $4.08 EPS for the last quarter, below analysts' expectations, despite a year-over-year revenue increase of 12.9% to $111.62 billion.

GDS Wealth Management grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,325 shares of the healthcare conglomerate's stock after buying an additional 2,181 shares during the quarter. GDS Wealth Management's holdings in UnitedHealth Group were worth $13,264,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the business. Capital Analysts LLC lifted its holdings in shares of UnitedHealth Group by 3.4% in the 1st quarter. Capital Analysts LLC now owns 11,427 shares of the healthcare conglomerate's stock valued at $5,986,000 after buying an additional 381 shares during the period. Humankind Investments LLC lifted its holdings in shares of UnitedHealth Group by 29.1% in the 1st quarter. Humankind Investments LLC now owns 3,265 shares of the healthcare conglomerate's stock valued at $1,710,000 after buying an additional 736 shares during the period. Vertex Planning Partners LLC acquired a new stake in shares of UnitedHealth Group in the 1st quarter valued at approximately $234,000. Banco Bilbao Vizcaya Argentaria S.A. lifted its holdings in shares of UnitedHealth Group by 18.2% in the 1st quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 63,606 shares of the healthcare conglomerate's stock valued at $33,331,000 after buying an additional 9,774 shares during the period. Finally, Van Lanschot Kempen Investment Management N.V. raised its holdings in UnitedHealth Group by 54.8% during the first quarter. Van Lanschot Kempen Investment Management N.V. now owns 73,672 shares of the healthcare conglomerate's stock worth $38,586,000 after purchasing an additional 26,066 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares of the company's stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.28% of the stock is currently owned by corporate insiders.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $303.77 on Wednesday. The company has a market cap of $275.12 billion, a P/E ratio of 13.16, a P/E/G ratio of 1.99 and a beta of 0.43. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The business has a fifty day simple moving average of $289.03 and a 200-day simple moving average of $393.55.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group's revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the prior year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. UnitedHealth Group's payout ratio is currently 38.30%.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. TD Cowen cut UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective for the company. in a report on Monday, May 19th. Hsbc Global Res cut UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a report on Wednesday, May 21st. TD Securities reaffirmed a "hold" rating and set a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Wolfe Research cut their price target on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. Finally, Barclays reissued an "overweight" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Fifteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of "Moderate Buy" and a consensus price target of $367.71.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.